Last updated: October 23, 2023
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting
Phase
3
Condition
Hypoparathyroidism
Treatment
ICG
Control group
Clinical Study ID
NCT04785443
29BRC20.0208
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient having to undergo a total thyroidectomy
- Signed consent
- Patient beneficiary of a social security regimen
Exclusion
Exclusion Criteria:
- Minor patient under 18 years old
- Major patient protected by law or unable to give informed consent
- Pregnant or breastfeeding woman
- Thyroidectomy totalization
- History of thyroid or parathyroid surgery
- Participation refusal
- Known allergy to ICG
- Woman of child-bearing age not using adequate method of contraception
Study Design
Total Participants: 242
Treatment Group(s): 2
Primary Treatment: ICG
Phase: 3
Study Start date:
June 22, 2021
Estimated Completion Date:
March 31, 2025
Study Description
Connect with a study center
CHRU de Brest
Brest, 29609
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.